- Home
- TULP vs NAII Comparison
TULP vs NAII Comparison
Compare TULP & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TULP | NAII |
|---|---|---|
| Founded | 1990 | 1980 |
| Country | United States | United States |
| Employees | 160 | N/A |
| Industry | Farming/Seeds/Milling | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 15.8M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | TULP | NAII |
|---|---|---|
| Price | $3.65 | $2.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.1K | ★ 31.6K |
| Earning Date | 02-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $132,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.48 | ★ N/A |
| Revenue Growth | N/A | ★ 8.60 |
| 52 Week Low | $3.50 | $2.22 |
| 52 Week High | $4.79 | $4.96 |
Technical Indicators
Market Signals| Indicator | TULP | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 29.46 |
| Support Level | $3.62 | N/A |
| Resistance Level | $4.10 | $2.79 |
| Average True Range (ATR) | 0.14 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 27.10 | 12.00 |
Price Performance
Historical ComparisonAbout TULP Bloomia Holdings Inc. Common Stock
Bloomia Holdings Inc is a specialty ag company focused on making and managing its ag investments in the U.S. and internationally. The Company is the majority owner of Bloomia, one of the largest producers of fresh-cut tulips in the United States.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.